| Literature DB >> 26329472 |
Leopoldo J Cabassa1, Ana Stefancic2, Kathleen O'Hara3, Nabila El-Bassel4, Roberto Lewis-Fernández5, José A Luchsinger6, Lauren Gates7, Richard Younge8, Melanie Wall9, Lara Weinstein10, Lawrence A Palinkas11.
Abstract
BACKGROUND: The risk for obesity is twice as high in people with serious mental illness (SMI) compared to the general population. Racial and ethnic minority status contribute additional health risks. The aim of this study is to describe the protocol of a Hybrid Trial Type 1 design that will test the effectiveness and examine the implementation of a peer-led healthy lifestyle intervention in supportive housing agencies serving diverse clients with serious mental illness who are overweight or obese.Entities:
Mesh:
Year: 2015 PMID: 26329472 PMCID: PMC4557630 DOI: 10.1186/s13063-015-0902-z
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Fig. 1Conceptual framework for effectiveness and implementation research
Fig. 2Hybrid Trial Type 1 design
Eligibility criteria for effectiveness trial
| Inclusion criteria | |
| Demographics | Male or female, 18 years of age or older, of any race/ethnicity, who are English and/or Spanish speakers and are receiving supportive housing services at the study sites |
| Mental health diagnosis | Chart diagnosis of a serious mental illness (e.g., schizophrenia, bipolar disorder, schizoaffective disorders, major depression) |
| Body mass index | BMI ≥ 25 (kg/m2) |
| Informed consent | Able and willing to give written informed consent to participate in study |
| Willingness to obtain medical clearance | Able and willing to obtain a medical clearance letter from a primary care physician with assistance from the study team if randomly assigned to the Peer GLB group |
| Exclusion criteria | |
| Substance abuse | Need for detoxification services at the time of recruitment |
| Suicidal/Homicidal ideation | Pose a danger to self or others at the time of recruitment |
| Capacity to consent | Failed capacity-to-consent questionnaire [ |
| Cognitive impairment | For participants 65 years or older: screen positive for cognitive impairment based on Mini-cog clock test [ |
| Medical contraindications to participate in weight loss program | Self-report of any of the following medical conditions that are contraindicated to participation in a weight loss program: cancer requiring active treatment, liver failure, history of anorexia nervosa, cardiovascular event (e.g., unstable angina, myocardial infarction) within the past 6 months, walking limitations preventing participation in exercise, history of weight loss surgery or planning weight loss surgery during study period, and (for female participants) pregnant or planning a pregnancy during study period. |
| (Exclusion criteria for participants randomized to the intervention group: primary care physician confirms that the person has any of the following medical conditions: cancer requiring active treatment, liver failure, history of anorexia nervosa, cardiovascular event (e.g., unstable angina, myocardial infarction) within the past 6 months, walking limitations preventing participation in exercise, history of weight loss surgery or planning weight loss surgery during study period, and (for female participants) pregnant or planning a pregnancy during study period |
GLB Group Lifestyle Balance
Effectiveness trial measures
| Type of Variable | Construct | Description | Timeline |
|---|---|---|---|
| Primary Outcome | Weight | Measured in lbs in light indoor clothing without shoes using a digital scale. | B, 6, 12,18 |
| Secondary Outcomes | Anthropometrics | Waist circumference measured to the nearest 0.1 cm with an anthropometric tape, in a horizontal plane 1 cm above the navel in light indoor clothing. Blood pressure assessed on the right arm of participants after they rest quietly in a seated position for at least 5 minutes, using a validated automated sphygmomanometer. Height measured without shoes with an anthropometric tape to the nearest 0.1 cm at entry into the study. Body mass index: will be calculated from measured height and weight (kg/m2) | B, 6, 12,18 |
| Self-efficacy | The Weight Efficacy Lifestyle (WEL) Questionnaire is a 20-item scale that asks people to rate their confidence to resist eating in certain situations on a 10-point Likert scale ranging from 0 (not confident) to 9 (very confident) [ | B, 6, 12,18 | |
| Physical activity | The International Physical Activity Questionnaire (IPAQ) short form [ | B, 6, 12,18 | |
| Dietary behaviors | The Block Fat Screener and Fruit, Vegetable and Fiber Screener Questionnaires are brief food frequency measures that provide valid assessments of the intake of these foods [ | B, 6, 12,18 | |
| Recovery | The Recovery Assessment Scale [ | B, 6, 12,18 | |
| Quality of Life | SF-12 [ | B, 6, 12,18 | |
| Moderators | Demographics | Self-reported age, gender, race/ethnicity, education, income, and marital status | B |
| Psychiatric medications | Self-reported list of psychiatric medications prescribed. Type and dosage will be recorded | B, 6, 12,18 | |
| Attitudes toward Peer GLB | Modified version of the Client Satisfaction Questionnaire, an 8-item self-report scale available in English and Spanish to assess participants’ attitudes (e.g., satisfaction, acceptability) toward Peer GLB [ | 6, 12, 18 | |
| Mental health | We will use the Revised Behavior and Symptom Identification Scale (BASIS-R) [ | B, 6, 12,18 | |
| Covariates | Acculturation, barriers to medical care, comorbid medical conditions, service use and alcohol/drug use | Acculturation: nativity, language preference, time in the US, age of migration. The Bidimensional Acculturation Scale [ | B, 6, 12,18 |
B baseline, GLB Group Lifestyle Balance
Summary of mixed-methods implementation study
| Methods | Participants | Projected sample size | Implementation factors examined | Timing | ||
|---|---|---|---|---|---|---|
| Pre-RCT | During the RCT | Post-RCT | ||||
| Semi-structured qualitative interviews | Agency directors and program managers | 6 | System-level and organizational-level factors | X | X | |
| Surveys | Direct service providers, including peer specialists | 45 | Organizational-level and staff-level factors | X | X | |
| Focus groups | Direct service providers and peer specialists | 30 | Organizational-level and staff-level factors | X | X | |
| Participant observation | Agency directors, program managers, direct service providers, peer specialists, clients | NA | System-level, organizational-level, and staff-level factors | X | X | X |
NA not applicable, RCT randomized controlled trial